These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2945294)

  • 21. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.
    Motta M; Giugno I; Ruello P; Pistone G; Di Fazio I; Malaguarnera M
    Minerva Med; 2001 Oct; 92(5):301-5. PubMed ID: 11675573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selected parameters of lipoprotein metabolism in cerebrovascular diseases].
    Drobný M; Svaleková A; Kosková E; Hazlingerová M; Celec S
    Bratisl Lek Listy; 1996 May; 97(5):267-72. PubMed ID: 8705323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
    Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregation of plasma lipids and lipoproteins in families with and without coronary heart disease.
    Friedlander Y; Kark JD; Fainaru M; Gotsman M; Stein Y
    Atherosclerosis; 1985 Nov; 57(2-3):235-47. PubMed ID: 4084357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipids after stroke.
    Mendez I; Hachinski V; Wolfe B
    Neurology; 1987 Mar; 37(3):507-11. PubMed ID: 3822149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study.
    Frost PH; Verter J; Miller D
    Am Heart J; 1987 Jun; 113(6):1356-64. PubMed ID: 3591604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
    Lippi G; Arosio E; Prior M; Guidi G
    Angiology; 2001 Oct; 52(10):681-7. PubMed ID: 11666132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: the Tallinn myocardial infarction study.
    Aasvee K; Kurvinen E; Sundvall J; Jauhiainen M; Tur I
    Clin Chem Lab Med; 2008; 46(11):1602-8. PubMed ID: 19012525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.
    Habib SS; Abdel-Gader AM; Kurdi MI; Al-Aseri Z; Soliman MM
    Saudi Med J; 2009 Mar; 30(3):346-52. PubMed ID: 19271061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.
    Manita D; Yoshida H; Hirowatari Y
    J Atheroscler Thromb; 2017 Sep; 24(9):928-939. PubMed ID: 28025448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia.
    Nozue T; Michishita I; Mizuguchi I
    J Atheroscler Thromb; 2010 Feb; 17(1):37-44. PubMed ID: 20075599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations of high-density lipoprotein (HDL)-2 and HDL-3 in myocardial infarction survivors and in control subjects.
    Brugger P; Kostner GM; Kullich WC; Klein G
    Clin Cardiol; 1986 Jun; 9(6):273-6. PubMed ID: 3720050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical composition of ultracentrifugal fractions in different patterns of human atheroslcerosis.
    Avogaro P; Cazzolato G; Taroni GC; Belussi F
    Atherosclerosis; 1977 Feb; 26(2):163-72. PubMed ID: 189783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.
    Sandkamp M; Funke H; Schulte H; Köhler E; Assmann G
    Clin Chem; 1990 Jan; 36(1):20-3. PubMed ID: 2137054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of serum lipids and serum lipoprotein spectrum in patients with cerebrovascular diseases.
    Zhou J; Zhang M; Li XM
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):262-4. PubMed ID: 12651248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.